ATE201021T1 - (r)-5-bromo-n-(1-ethyl-4-methylhexahydro-1h-1,4 diazepin-6-yl)-2-methoxy-6-methylamino-3- pyridincarboxamid, verfahren zu seinerherstellung und dieses enthaltende medizinische zubereitung - Google Patents

(r)-5-bromo-n-(1-ethyl-4-methylhexahydro-1h-1,4 diazepin-6-yl)-2-methoxy-6-methylamino-3- pyridincarboxamid, verfahren zu seinerherstellung und dieses enthaltende medizinische zubereitung

Info

Publication number
ATE201021T1
ATE201021T1 AT96924189T AT96924189T ATE201021T1 AT E201021 T1 ATE201021 T1 AT E201021T1 AT 96924189 T AT96924189 T AT 96924189T AT 96924189 T AT96924189 T AT 96924189T AT E201021 T1 ATE201021 T1 AT E201021T1
Authority
AT
Austria
Prior art keywords
4diazepine
methylhexahydro
methylamino
bromo
methoxy
Prior art date
Application number
AT96924189T
Other languages
English (en)
Inventor
Shiro Kato
Yoshimi Hirokawa
Toshiya Morie
Hiroshi Harada
Naoyuki Yoshida
Original Assignee
Dainippon Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co filed Critical Dainippon Pharmaceutical Co
Application granted granted Critical
Publication of ATE201021T1 publication Critical patent/ATE201021T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/08Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
AT96924189T 1995-07-28 1996-07-23 (r)-5-bromo-n-(1-ethyl-4-methylhexahydro-1h-1,4 diazepin-6-yl)-2-methoxy-6-methylamino-3- pyridincarboxamid, verfahren zu seinerherstellung und dieses enthaltende medizinische zubereitung ATE201021T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP07212495 1995-07-28
PCT/JP1996/002053 WO1997005129A1 (fr) 1995-07-28 1996-07-23 (r)-5-bromo-n-(1-ethyl-4-methylhexahydro-1h-1,4-diazepin-6-yl)-2-methoxy-6-methylamino-3-pyridine-carboxamide, son procede d'obtention et medicament le contenant

Publications (1)

Publication Number Publication Date
ATE201021T1 true ATE201021T1 (de) 2001-05-15

Family

ID=16623612

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96924189T ATE201021T1 (de) 1995-07-28 1996-07-23 (r)-5-bromo-n-(1-ethyl-4-methylhexahydro-1h-1,4 diazepin-6-yl)-2-methoxy-6-methylamino-3- pyridincarboxamid, verfahren zu seinerherstellung und dieses enthaltende medizinische zubereitung

Country Status (25)

Country Link
US (1) US5945415A (de)
EP (1) EP0855397B1 (de)
KR (1) KR19990028395A (de)
CN (1) CN1096459C (de)
AT (1) ATE201021T1 (de)
AU (1) AU700635B2 (de)
BR (1) BR9609691A (de)
CA (1) CA2228056A1 (de)
CZ (1) CZ290442B6 (de)
DE (1) DE69612753T2 (de)
DK (1) DK0855397T3 (de)
ES (1) ES2156616T3 (de)
GR (1) GR3036089T3 (de)
HK (1) HK1018049A1 (de)
HU (1) HUP9901208A3 (de)
IL (1) IL122753A (de)
MX (1) MX9800620A (de)
NO (1) NO312964B1 (de)
NZ (1) NZ312799A (de)
PL (1) PL184073B1 (de)
PT (1) PT855397E (de)
RU (1) RU2156248C2 (de)
SK (1) SK282044B6 (de)
TR (1) TR199800165T1 (de)
WO (1) WO1997005129A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19650778C2 (de) * 1996-12-06 2001-01-04 Asta Medica Ag Verwendung von Dopaminrezeptor-Antagonisten in der palliativen Tumortherapie
GB0216027D0 (en) * 2002-07-10 2002-08-21 Arachnova Therapeutics Ltd New therapeutic use
US20040048874A1 (en) * 2001-05-22 2004-03-11 Bardsley Hazel Judith New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine
ITBO20020198A1 (it) * 2002-04-12 2003-10-13 Univ Bologna Derivati 2 , 5 bis diammino 1 , 4 benzochenionici utili per il trattamento della malattia di alzheimer , metodo per la loro preparazione ed
BRPI0406749A (pt) * 2003-01-13 2005-12-20 Dynogen Pharmaceuticals Inc Métodos relacionados ao tratamento de distúrbios fincionais do intestino e composição farmacêutica
ATE359079T1 (de) * 2003-01-13 2007-05-15 Dynogen Pharmaceuticals Inc Verfahren zur behandlung von übelkeit, erbrechen, würgereiz oder jede kombination daraus
ATE365554T1 (de) * 2003-04-04 2007-07-15 Dynogen Pharmaceuticals Inc Methode zur behandlung von erkrankungen der unteren harnwege
US20060293309A1 (en) * 2005-03-28 2006-12-28 Dynogen Pharmaceuticals, Inc. Method of treating disorders and conditions using peripherally-restricted antagonists and inhibitors
AU2010231439A1 (en) 2009-03-31 2011-10-27 Zeria Pharmaceutical Co., Ltd. Method for manufacturing 1,5-benzodiazepine derivative
US9045460B2 (en) 2010-08-26 2015-06-02 Kowa Co., Ltd. Production method for isoquinoline derivatives and salts thereof
EP3102565B1 (de) * 2014-02-03 2019-01-02 Mylan Laboratories Ltd. Verfahren zur herstellung von raltegravir-intermediaten

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166341A (en) * 1988-07-29 1992-11-24 Dainippon Pharmaceutical Co., Ltd. 6-amino-1,4-hexahydro-1H-diazepine derivatives
US5017573A (en) * 1988-07-29 1991-05-21 Dainippon Pharmaceutical Co., Ltd. Indazole-3-carboxylic acid derivatives
JPH04210970A (ja) * 1990-01-26 1992-08-03 Dainippon Pharmaceut Co Ltd ベンズアミド誘導体及びその中間体
JPH03223265A (ja) * 1990-01-26 1991-10-02 Dainippon Pharmaceut Co Ltd 環状ジアミン誘導体
MX9206075A (es) * 1991-10-24 1993-04-01 Smithkline Beecham Plc Nuevos compuestos antagonistas del receptor 5-hidroxitriptamina y composiciones farmaceuticas que los contienen

Also Published As

Publication number Publication date
HUP9901208A3 (en) 2002-10-28
IL122753A0 (en) 1998-08-16
TR199800165T1 (xx) 1998-06-22
US5945415A (en) 1999-08-31
CN1096459C (zh) 2002-12-18
RU2156248C2 (ru) 2000-09-20
PL184073B1 (pl) 2002-08-30
CZ290442B6 (cs) 2002-07-17
PL324749A1 (en) 1998-06-08
NZ312799A (en) 1999-04-29
NO980333D0 (no) 1998-01-26
EP0855397A1 (de) 1998-07-29
KR19990028395A (ko) 1999-04-15
EP0855397A4 (de) 1998-12-02
CA2228056A1 (en) 1997-02-13
ES2156616T3 (es) 2001-07-01
WO1997005129A1 (fr) 1997-02-13
NO312964B1 (no) 2002-07-22
MX9800620A (es) 1998-04-30
DE69612753D1 (de) 2001-06-13
SK9398A3 (en) 1998-08-05
HK1018049A1 (en) 1999-12-10
DK0855397T3 (da) 2001-06-25
AU6471796A (en) 1997-02-26
GR3036089T3 (en) 2001-09-28
CZ23098A3 (cs) 1998-06-17
AU700635B2 (en) 1999-01-07
PT855397E (pt) 2001-08-30
DE69612753T2 (de) 2005-07-07
NO980333L (no) 1998-03-23
BR9609691A (pt) 1999-03-23
EP0855397B1 (de) 2001-05-09
CN1192213A (zh) 1998-09-02
IL122753A (en) 2000-10-31
HUP9901208A2 (hu) 2000-04-28
SK282044B6 (sk) 2001-10-08

Similar Documents

Publication Publication Date Title
ATE264337T1 (de) Glucopyranosyloxypyrazol-derivate, diese enthaltende arzneimittel und zwischenprodukte zu deren herstellung
HUP0102851A2 (hu) Parazitaellenes artemizinin-származékok (endoperoxidok), eljárás előállításukra és a vegyületeket tartalmazó gyógyászati készítmények
MY132565A (en) Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor alpha (ppar)
ATE208379T1 (de) 1-phenylpyrozol-verbindungen und ihre medizinische anwendung
FI943948A0 (fi) Heterosykliset hiilihappojohdannaiset
ATE201021T1 (de) (r)-5-bromo-n-(1-ethyl-4-methylhexahydro-1h-1,4 diazepin-6-yl)-2-methoxy-6-methylamino-3- pyridincarboxamid, verfahren zu seinerherstellung und dieses enthaltende medizinische zubereitung
CA2157792A1 (en) N-(3-piperidinyl-carbonyl)-beta-alanine derivatives as paf antagonists
ATE318266T1 (de) 3-substituierte chinolin-4- carbonsäureamidderivate als nk-3- und nk-2- rezeptorantagonisten
DK132188D0 (da) Anvendelse af tetrahydrobenz(c,d)indol-6-carboxamider som anxiolytika
PL304063A1 (en) Derivatives of 5-amino 9-methyl-7-pyrolidine-quinoline-3-carboxylic acid, method of obtaining them, pharmaceutic agent containing such compounds and medical treatment method employing them
FI92320B (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten bisfenyylialkyylipiperatsiinijohdannaisten valmistamiseksi
NO302821B1 (no) Aminobenzosyrederivat, preparat omfattende derivatet og anvendelse av derivatet
FI964303A0 (fi) Keuhkosydänvian hoitamiseen tarkoitettu aine
NO20042881L (no) Substituerte cykloheksan-derivater
AU3375893A (en) Intermediates of n-hydroxy-dibenz(b,e)oxepin-alkylamines and -alkanoic acid amides, related heterocyclic analogues, a process for their preparation and their use as medicaments
DK1142575T3 (da) Lægemidler til tör hud
AU2013888A (en) Uricosuric composition

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee